Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrosing Interstitial Lung Disease”

Showing 10 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00359736
What this trial is testing

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

Who this might be right for
Alveolitis, FibrosingFibrosis, PulmonaryHypertension, Pulmonary
VA Office of Research and Development 29
Not applicableLooking for participantsNCT06182748
What this trial is testing

Physical Activity and Fibrosing Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lungs Diseases
Assistance Publique - Hôpitaux de Paris 60
Not applicableUnknownNCT05635032
What this trial is testing

Fibrosing ILD Biomarkers That Rule Acceleration

Who this might be right for
Pulmonary FibrosisSarcoidosis
Universidade do Porto 150
Not applicableLooking for participantsNCT06537934
What this trial is testing

Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases

Who this might be right for
Interstitial Lung Diseases
IRCCS San Raffaele 123
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Large-scale testing (Phase 3)Study completedNCT05285982
What this trial is testing

Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 54
Not applicableStudy completedNCT04559581
What this trial is testing

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 425
Large-scale testing (Phase 3)Study completedNCT05065190
What this trial is testing

Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 81
Not applicableStudy completedNCT05875532
What this trial is testing

Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 34,960
Not applicableNo Longer AvailableNCT05624281
What this trial is testing

A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)
Boehringer Ingelheim

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation